Publications by authors named "P A Novikov"

Purpose: This study investigates the capabilities of ultrasonography (US) in determing the stage of orbital inflammation in patients with granulomatosis with polyangiitis (GPA).

Material And Methods: The study included 24 patients (8 men and 16 women) with diffuse orbital tissue involvement in GPA. Group 1 (active stage) included nine patients, while group 2 (inactive stage) consisted of 18 patients.

View Article and Find Full Text PDF

In recent years, 3D printing has emerged as a promising technology in energy storage, particularly for the fabrication of Li-ion battery electrodes. This innovative manufacturing method offers significant material composition and electrode structure flexibility, enabling more complex and efficient designs. While traditional Li-ion battery fabrication methods are well-established, 3D printing opens up new possibilities for enhancing battery performance by allowing for tailored geometries, efficient material usage, and integrating multifunctional components.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to investigate the relationship between clinical and morphological features of kidney issues in patients with systemic lupus erythematosus (SLE).
  • A total of 62 patients with lupus nephritis (LN) were examined, revealing that most were female and had a median age of SLE onset around 23 years; various extrarenal symptoms were noted alongside kidney involvement.
  • The findings showed significant variation in LN presentations, emphasizing the necessity of kidney biopsies for accurate classification, as similar symptoms like proteinuria were observed across different LN classes.
View Article and Find Full Text PDF

Unlabelled: The aim of the study was to evaluate the clinical manifestations and survival of patients with giant cell arteritis (GCA).

Materials And Methods: . A retrospective study included 166 patients with newly diagnosed GCA.

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated the effectiveness and safety of the IL-5 receptor inhibitor benralizumab for treating patients with eosinophilic granulomatosis with polyangiitis (EGPA) across 28 European centers.
  • Out of 121 patients treated, complete responses increased from 12.4% at 3 months to 46.4% at 12 months, while partial responses decreased over the same period.
  • Notable improvements were seen in disease activity, as measured by the Birmingham Vasculitis Activity Score (BVAS), and a reduction in various disease manifestations, alongside better lung function.
View Article and Find Full Text PDF